Pedro Ventura

Here below are the publications (1) participated by Pedro Ventura along with Alberto J. Arribas (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers

Haematologica, 1 novembre 2024

Facts & figures

Pedro Ventura has coordinated or participated in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 13 elements tag cloud:

bacterial lysate (1) BALF (1) hematologic cancers (1) MYC (1) myeloid cells (1) NK cells (1) PD-1 checkpoint blockade (1) Ptpn11 (1) Ptpn6 (1) T cell exhaustion (1) TLR2 (1) TLR4 (1) Wiskott-Aldrich syndrome (1)

Pedro Ventura has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 4 scientific journals:

Haematologica (2) EMBO Reports (1) Life Science Alliance (1) Mucosal Immunology (1)

Pedro Ventura has coordinated or participated in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 34 co-authors being active in Ticino:

Greta Guarda (5) Andrea Rinaldi (4) Francesco Bertoni (3) Alessandro Zenobi (3) Andrea Cavalli (3) Hanif J. Khameneh (3) Filippo Spriano (2) Emanuele Zucca (2) Anastasios Stathis (2) Alberto Furlan (2) Luciano Cascione (2) Jacopo Sgrignani (2) Gaetanina Golino (2) Francesco Margheriti (2) Eugenio Gaudio (2) Berenice A. Fischer (2) Laura Barnabei (2) Giulio Sartori (2) Franco Cavalli (2) Matteo Pecoraro (1) Chiara Tarantelli (1) Maurizio Bernasconi (1) Jessica Guerra (1) Federica Sallusto (1) Nicolas Fonta (1) Ivo Kwee (1) Concetta Guerra (1) Chaira Tarantelli (1) Alberto J. Arribas (1) Simone G. Moro (1) Alberto Jesus Arribas (1) Marco Bolis (1) Irene Buzzago (1) Roger Geiger (1)

Pedro Ventura has coordinated or participated in 5 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 28 most frequently used terms (excluding 21 not relevant terms) are here listed:

P.V. WORD CLOUD ptpn (2) first-in-class (2) wiskott-aldrich (2) activator (2) hematologic (2) cancers (2) concomitant (1) fails (1) anticancer (1) myc (1) controls (1) nk (1) il (1) driven (1) expansion (1) translational (1) machinery (1) bacterial (1) lysate (1) om (1) engages (1) toll-like (1) receptors (1) triggering (1) immunomodulatory (1) myeloid (1) antitumor (1) anti-tumor (1)

In the synopsis of the whole 3138 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 173 most frequently used terms (excluding 21 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (281) covid- (182) thyroid (108) sars-cov- (102) prostate (101) pet (101) cardiac (97) hiv (83) atrial (75) coronary (75) breast (74) pandemic (67) sclerosis (67) lymphoma (66) fibrillation (65) bone (53) aortic (51) artery (49) heart (48) liver (46) stroke (46) brain (43) carcinoma (43) antibodies (41) lung (38) mri (38) cardiovascular (36) transcatheter (35) ventricular (35) nodules (34) dna (34) virus (33) extracellular (32) metastatic (32) myocardial (31) tumor (30) kidney (29) oncology (29) ultrasound (28) knee (27) esmo (26) f-fdg (26) antibody (26) vesicles (25) spinal (25) mitral (25) hepatitis (24) ischemic (23) cervical (23) infarction (22) tuberculosis (22) ehra (22) antiplatelet (22) diabetes (22) sperm (22) pulmonary (21) radiotherapy (21) chemotherapy (21) renal (21) ovarian (21) percutaneous (21) osteoarthritis (20) implantation (20) vaccination (20) sentinel (20) transplantation (19) blood (19) nuclear (18) urinary (18) tomography (18) pacing (18) tumors (18) bacterial (18) b-cell (17) resonance (17) endovascular (17) monoclonal (17) bladder (17) lymph (17) laparoscopic (17) colorectal (17) mice (17) coronavirus (16) immunodeficiency (16) transplant (15) musculoskeletal (15) vascular (15) fdg (15) implantable (15) lymphomas (14) plasma (14) vaccine (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) autoimmune (13) mrna (13) biomarker (13) nerve (13) pneumonia (13) biomarkers (13) radiomics (13) metabolic (13) tricuspid (13) preclinical (13) metabolism (13) serum (13) metastasis (13) pregnancy (13) lymphocytic (13) conference (12) malignancy (12) membrane (12) grafts (12) ischemia (12) endometrial (12) fna (12) joint (12) brugada (12) antiretroviral (12) legs (12) male (12) arterial (12) dementia (12) esc (12) hemorrhage (12) behavior (12) pi (11) burden (11) cytology (11) signaling (11) pathways (11) contemporary (11) adherence (11) catheter (11) contrast-enhanced (11) limb (11) tau (11) parkinson (11) radiation (11) senescence (11) neck (11) hiv- (11) mesenchymal (11) lockdown (11) mutations (11) medullary (11) il- (11) infectious (10) cancers (10) igg (10) intravenous (10) arrhythmia (10) vitamin (10) interventions (10) prophylaxis (10) migraine (10) follicular (10) gastric (10) prognosis (10) metastases (10) skin (10) incontinence (10) muscle (10) anesthesia (10) epidemiology (10) lipid (10) baseline (10) refractory (10) malignant (10) occlusion (10) dynamic (10)

Scientific researchers in Ticino

Pedro Ventura has participated - as a whole - in 5 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alberto J. Arribas

1) A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers

Pedro Ventura has participated - as a whole - in 5 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Alberto J. Arribas